As we anticipated now that the Tandem (NASDAQ: TNDM) has completed the reverse stock split they are headed back to the capital markets – again – asking for money – again – and in the process diluting the stock – again – so they can waste more investor money – again. Per a company press release;
“Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced that it is proposing to offer and sell shares of its common stock, Series A warrants and Series B warrants to purchase shares of its common . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.